Myriad Genetics Inc
$3.935
USD
Last updated on --.
24h volume866.01K
24h highest3.9500 USD
24h lowest3.8250 USD
24h Price movement+2.21%
MYGN recent prices
24 Hours
+2.21%+$0.085
30 days
-20.14%-$0.975
60 days
-11.35%-$0.495
90 days
-16.16%-$0.745
Key data
Previous close3.8500 USD
Market cap359.85M USD
Volume866.01K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.2300 USD
Net income (FY)-399.90M USD
Revenue (FY)829.00M USD
Last report date6 May 2026
About Myriad Genetics Inc
HeadquartersSALT LAKE CITY
Employees (FY)2.70K
Revenue per employee (FY)307.04K USD
Net income per employee (FY)-148.11K USD
Listed onNasdaq
MYGN conversion tables
 |  |
|---|---|
| 0.5 MYGN | 1.967 USD |
| 1 MYGN | 3.935 USD |
| 5 MYGN | 19.67 USD |
| 10 MYGN | 39.35 USD |
| |
|---|---|
| 0.5 USD | 0.12706 MYGN |
| 1 USD | 0.25413 MYGN |
| 5 USD | 1.270 MYGN |
| 10 USD | 2.541 MYGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
MYGN is trading at $3.935, +2.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MYGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MYGN is currently trading at $3.935, +2.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MYGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MYGN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MYGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MYGN's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Myriad Genetics Inc's market cap is currently 359.85M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume866.01K
24h highest3.9500 USD
24h lowest3.8250 USD
24h Price movement+2.21%
Start trade with MYGN Perpetual
Sign up to trade